Pembrolizumab for Early Triple-Negative Breast Cancer
Among patients with early triple-negative breast cancer, the percentage with a pathological complete response was significantly higher among those who received pembrolizumab plu...
Publications
2 shownBreast cancer
Breast cancer is still the most common cancer worldwide. But the way breast cancer is viewed has changed drastically since its molecular hallmarks were extensively characterised...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 4,151
- Institution
- Philipps University of Marburg
External Links
Identifiers
- ORCID
- 0000-0002-2249-0982
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.